Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Net LoansDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nomura Holdings (NMR) Change in Accured Expenses (2016 - 2024)

Nomura Holdings has reported Change in Accured Expenses over the past 16 years, most recently at $327.7 million for Q1 2024.

  • For Q1 2024, Change in Accured Expenses rose 22.93% year-over-year to $327.7 million; the TTM value through Mar 2024 reached $131.5 million, up 291.37%, while the annual FY2026 figure was $404.4 million, 132.86% up from the prior year.
  • Change in Accured Expenses for Q1 2024 was $327.7 million at Nomura Holdings, up from $277.3 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $414.1 million in Q4 2020 and troughed at -$850.4 million in Q2 2021.
  • A 5-year average of $17.3 million and a median of $240.1 million in 2022 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 147.37% in 2021 and later surged 472.23% in 2022.
  • Year by year, Change in Accured Expenses stood at $414.1 million in 2020, then dropped by 19.59% to $333.0 million in 2021, then decreased by 27.89% to $240.1 million in 2022, then increased by 15.5% to $277.3 million in 2023, then increased by 18.18% to $327.7 million in 2024.
  • Business Quant data shows Change in Accured Expenses for NMR at $327.7 million in Q1 2024, $277.3 million in Q4 2023, and $246.9 million in Q3 2023.